Sezolamide: Additivity to timolol twice daily

@article{Gunning1992SezolamideAT,
  title={Sezolamide: Additivity to timolol twice daily},
  author={F. Gunning and A. B{\'e}chetoille and E. Lippa and N. Pfeiffer and J. Gerling and D. Holder and C. Clineschmidt and A. Buntinx and F. Brunner‐Ferber and F. Grehn and E. Gr{\`e}ve},
  journal={Eye},
  year={1992},
  volume={6},
  pages={525-529}
}
Sezolamide, a potent topical carbonic anhydrase inhibitor previously known as MK-417, was studied to determine its ocular hypotensive activity in patients with elevated intraocular pressure while on continuing therapy with topical timolol. This was a three-centre, double-masked, randomised, placebo-controlled, parallel study in 36 patients with bilateral primary open angle glaucoma or ocular hypertension on therapy receiving 0.5% timolol twice daily, with a morning intraocular pressure greater… Expand
6 Citations

References

SHOWING 1-10 OF 33 REFERENCES
MK-927: a topically effective carbonic anhydrase inhibitor in patients.
Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma.
  • E. Keates
  • Medicine
  • American journal of ophthalmology
  • 1979
[Timolol and acetazolamide in the treatment of increased intraocular pressure (author's transl)].
  • A. Scharrer, M. Ober
  • Medicine
  • Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology
  • 1979
...
1
2
3
4
...